Accenture and Google Cloud Collaborate to Help Life Sciences Companies Advance the Discovery, Development and Delivery of Innovative Therapies

By Associated Press 29 January 2020, 12:00AM

NEW YORK & SUNNYDALE, Calif.--(BUSINESS WIRE)--Jan 28, 2020--

Accenture (NYSE:ACN) and Google Cloud (NASDAQ:GOOG, GOOGL) today announced that Google Cloud will be the cloud technology provider for Accenture’s INTIENT™ life sciences industry platform.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200128005285/en/

(Photo: Business Wire)

The new, multi-year agreement brings Google’s cloud and artificial intelligence capabilities together with Accenture’s life sciences services and platforms and is intended to help life sciences organizations make their data more accessible, secure and valuable.

The INTIENT platform provides life sciences organizations with end-to-end capabilities from discovery and research to clinical development and the delivery of treatments. Accenture launched INTIENT in May 2019, building on more than seven years of collaboration with over 25 life sciences companies to develop and deploy platform technology solutions.

“INTIENT will advance Accenture’s and Google Cloud’s shared mission to empower life sciences organizations with intelligent solutions that help bring innovative treatments to patients around the world, with greater speed, safety, and efficacy,” said Simon Eaves, group chief executive of Products at Accenture. “Together, we can deliver exceptional value to clients at a rapid pace.”

Google Cloud’s architecture supports open source technology that will enable Accenture to expand the capabilities of INTIENT by allowing partners, independent software vendors, and content providers to rapidly develop and provide additional solutions that extend the value of the platform.

Tariq Shaukat, president at Google Cloud, said, “We’re excited to partner with Accenture to transform the life sciences industry with cloud technologies. Our shared goal is to accelerate developments in treatments by leveraging powerful Google Cloud capabilities, such as AI and data analytics, to gain insights that correlate symptoms, events, and treatments in new and unexpected ways.”

Under the terms of the agreement, Google Cloud will be the cloud technology provider for current and future solutions that are a part of the Accenture INTIENT platform for life sciences. The agreement is an extension of the partnership between Accenture and Google built over the last eight years. A key milestone in the relationship was the July 2018 launch of the Accenture Google Cloud Business Group, which helps companies use Google Cloud technology to deliver superior customer experiences and accelerate their digital transformation journeys.

About Accenture
Accenture is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. Combining unmatched experience and specialized skills across more than 40 industries and all business functions — underpinned by the world’s largest delivery network — Accenture works at the intersection of business and technology to help clients improve their performance and create sustainable value for their stakeholders. With 505,000 people serving clients in more than 120 countries, Accenture drives innovation to improve the way the world works and lives. Visit us at www.accenture.com.

About Google Cloud
Google Cloud provides organizations with leading infrastructure, platform capabilities and industry solutions, along with expertise, to reinvent their business with data-powered innovation on modern computing infrastructure. We deliver enterprise-grade cloud solutions that leverage Google’s cutting-edge technology to help companies operate more efficiently, modernize for growth and innovate for the future. Customers in more than 150 countries turn to Google Cloud as their trusted partner to solve their most critical business problems.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200128005285/en/

CONTACT: Lara Wozniak

Accenture

+1 858 252 8208

[email protected] Tsai

Accenture

+1 917 452 9729

[email protected]

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA NEW YORK

INDUSTRY KEYWORD: SOFTWARE RESEARCH NETWORKS PHARMACEUTICAL DATA MANAGEMENT TECHNOLOGY FITNESS & NUTRITION SCIENCE BIOTECHNOLOGY OTHER TECHNOLOGY OTHER SCIENCE HEALTH

SOURCE: Accenture

Copyright Business Wire 2020.

PUB: 01/28/2020 08:59 AM/DISC: 01/28/2020 08:59 AM

http://www.businesswire.com/news/home/20200128005285/en

By Associated Press 29 January 2020, 12:00AM

Trending Stories

Samoa Observer

Upgrade to Premium

Subscribe to
Samoa Observer Online

Enjoy unlimited access to all our articles on any device + free trial to e-Edition. You can cancel anytime.

>